These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11559421)

  • 1. Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression.
    Gange SJ; Mellors JW; Lau B; Detels R; Phair JP; Muñoz A; Margolick JB
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1223-9. PubMed ID: 11559421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons.
    Bruisten SM; Frissen PH; Van Swieten P; Harrigan PR; Kinghorn I; Larder B; Weigel HM; De Vries E; Regez RM; Henrichs JH; Koot M; Huisman JG
    AIDS Res Hum Retroviruses; 1997 Mar; 13(4):327-35. PubMed ID: 9071432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
    Mellors JW; Muñoz A; Giorgi JV; Margolick JB; Tassoni CJ; Gupta P; Kingsley LA; Todd JA; Saah AJ; Detels R; Phair JP; Rinaldo CR
    Ann Intern Med; 1997 Jun; 126(12):946-54. PubMed ID: 9182471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
    Jurriaans S; Van Gemen B; Weverling GJ; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J
    Virology; 1994 Oct; 204(1):223-33. PubMed ID: 7916514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.
    Keet IP; Janssen M; Veugelers PJ; Miedema F; Klein MR; Goudsmit J; Coutinho RA; de Wolf F
    J Infect Dis; 1997 Sep; 176(3):665-71. PubMed ID: 9291313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of plasma HIV-1 RNA concentrations during the asymptomatic stage of HIV infection measured using AMPLICOR HIV monitor and NASBA HIV-1 RNA QT tests. ACCTES Association.
    Delamare C; Burgard M; Deveau C; Chaix ML; Ivanoff S; Ramirez D; Tachet A; Bary M; Rouzioux C
    J Med Virol; 1998 Jan; 54(1):60-8. PubMed ID: 9443110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
    Katzenstein TL; Pedersen C; Nielsen C; Lundgren JD; Jakobsen PH; Gerstoft J
    AIDS; 1996 Feb; 10(2):167-73. PubMed ID: 8838704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.
    Learmont JC; Geczy AF; Mills J; Ashton LJ; Raynes-Greenow CH; Garsia RJ; Dyer WB; McIntyre L; Oelrichs RB; Rhodes DI; Deacon NJ; Sullivan JS
    N Engl J Med; 1999 Jun; 340(22):1715-22. PubMed ID: 10352163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
    Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
    AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
    Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
    AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.
    Mellors JW; Margolick JB; Phair JP; Rinaldo CR; Detels R; Jacobson LP; Muñoz A
    JAMA; 2007 Jun; 297(21):2349-50. PubMed ID: 17551128
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
    Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
    AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein is a marker for human immunodeficiency virus disease progression.
    Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
    Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/l.
    Chapman LE; Green TA; Ahmed F; Parekh BS; Rimland D; Kaplan JE; Thompson MA; Folks TM
    AIDS; 2000 Jun; 14(9):1135-46. PubMed ID: 10894277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.